Determinants of poor dental care in patients with schizophrenia: A historical, prospective database study

Journal of Clinical Psychiatry

Volumn 72, Issue 2, 2011, Pages 140-143

  Nielsen, Jimmi ^a   Munk Jørgensen, Povl ^a   Skadhede, Søren ^a   Correll, Christoph U ^b,c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE;

ADULT; ARTICLE; DENTAL CARE; DISEASE REGISTRY; FEMALE; HEALTH STATUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHOLINERGIC ANTAGONISTS; CLOZAPINE; DENMARK; DENTAL CARE; DENTAL HEALTH SURVEYS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; UTILIZATION REVIEW;

EID: 79951961579     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05318yel     Document Type: Article

References (26)

1. McCreadie RG, Stevens H, Henderson J, et al. The dental health of people with schizophrenia. Acta Psychiatr Scand. 2004;110(4):306-310. doi:10.1/j.160-047.204.0373.x PubMed (Pubitemid 39278990)
2. Sayegh F, Dababneh R, Rodan R. Oral health status and dental treatment needs among non-institutionalized psychiatric patients. JRMS. 2006;13(1):27-31.
3. Stiefel DJ, Truelove EL, Menard TW, et al. A comparison of the oral health of persons with and without chronic mental illness in community settings. Spec Care Dentist. 1990;10(1):6-12.
4. Roca RP, Breakey WR, Fischer PJ. Medical care of chronic psychiatric outpatients. Hosp Community Psychiatry. 1987;38(7):741-745.
5. Hede B. Oral health in Danish hospitalized psychiatric patients. Community Dent Oral Epidemiol. 1995;23(1):44-48.
6. Velasco E, Machuca G, Martinez-Sahuquillo A, et al. Dental health among institutionalized psychiatric patients in Spain. Spec Care Dentist. 1997;17(6):203-206. doi:10.1/j.1754-4505.197.tb0897.x PubMed (Pubitemid 127737933)
7. Szabadi E, Tavernor S. Hypo- and hypersalivation induced by psychoactive drugs. CNS Drugs. 1999;11(6):449-466.
8. Fox PC, van der Ven PF, Sonies BC, et al. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc. 1985;110(4): 519-525.
9. Butt GM. Drug-induced xerostomia. J Can Dent Assoc. 1991; 57(5):391-393.
10. Jones RB. Tobacco or oral health: past progress, impending challenge. J Am Dent Assoc. 2000;131(8):1130-1136.
11. Hughes JR, Hatsukami DK, Mitchell JE, et al. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143(8):993-997.
12. Sjögren R, Nordström G. Oral health status of psychiatric patients. J Clin Nurs. 2000;9(4):632-638.
13. Leucht S, Burkard T, Henderson J, et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007;116(5):317-333. doi:10.1/j.160-047.207.01095.x PubMed (Pubitemid 47537428)
14. Munk-Jørgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull. 1997;44(1):82-84.
15. McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr Bull. 1993;19(1):71-84.
16. WHO Collaborating Centre for Drug Statistics Methodology. World Health Organization. ATC/DDD Index. 2009. http://www.whocc.no/ atc-ddd-index/. Revised October 27, 2009.
17. StatBank Denmark. Statistics Denmark. 2004. http://www.statistikbanken. dk/statbank5a/default.asp?w=1024. Accessed April 4, 2004.
18. Thomas A, Lavrentzou E, Karouzos C, et al. Factors which influence the oral condition of chronic schizophrenia patients. Spec Care Dentist. 1996;16(2):84-86. doi:10.1/j.1754-4505.196.tb0839.x PubMed (Pubitemid 126738503)
19. Ramon T, Grinshpoon A, Zusman SP, et al. Oral health and treatment needs of institutionalized chronic psychiatric patients in Israel. Eur Psychiatry. 2003;18(3):101-105. doi:10.1016/S0924-938(03)023-3 PubMed (Pubitemid 36644310)
20. Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry. 2003;64(1):30-34.
21. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9):789-796.
22. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620-627.
23. Kumra S, Charles Schulz S. Editorial: research progress in early-onset schizophrenia. Schizophr Bull. 2008;34(1):15-17. doi:10.1093/schbul/sbm123 PubMed (Pubitemid 350262291)
24. Friedlander AH, Marder SR. The psychopathology, medical management and dental implications of schizophrenia. J Am Dent Assoc. 2002;133(5):603-610, quiz 624-625.
25. Roick C, Fritz-Wieacker A, Matschinger H, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2007;42(4): 268-276. doi:10.107/s0127-07-0164-5 PubMed (Pubitemid 46455733)
26. Connolly M, Kelly C. Lifestyle and physical health in schizophrenia. Adv Psychiatr Treat. 2005;11(2):125-132. doi:10.192/apt.1.2.125 (Pubitemid 40331280)